Sterilization Validation for Implantable Devices

Abstract

Terminal sterilization of implantable medical devices must achieve a sterility assurance level (SAL) of 10^-6 -- one in a million probability of a non-sterile unit -- while preserving the mechanical integrity, biocompatibility, and functional performance of increasingly complex device materials including biodegradable polymers, drug-eluting coatings, biological tissues, and electronic components. Traditional sterilization validation follows ISO 11135 (ethylene oxide), ISO 11137 (radiation), or ISO 17665 (moist heat) through prescriptive dose-setting or cycle-development protocols, yet the proliferation of novel biomaterials and combination products has created sterilization compatibility challenges that standard protocols do not fully address. This study presents the Sterilization Validation Assessment Framework (SVAF), evaluating five sterilization modalities -- ethylene oxide (EO), gamma irradiation, electron beam (e-beam), vaporised hydrogen peroxide (VHP), and supercritical CO2 -- across four validation performance tasks: microbial lethality assurance, material compatibility preservation, residual toxicant control, and process robustness under worst-case conditions. Our Sterilization Validation Performance Score (SVPS) integrates SAL achievement, material degradation index, residual safety margin, process Cpk, and environmental sustainability. Electron beam achieved the highest SVPS (0.922) through rapid, low-temperature processing that delivered precise dose uniformity (DUR 1.04) with minimal material degradation across all tested biomaterials, while supercritical CO2 achieved the highest material compatibility (0.960) through non-ionising, low-temperature sterilization that preserved drug-eluting coating integrity and biological tissue viability.